Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

445 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +28 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Recruiting

Online Adaptive Stereotactic Body Radiotherapy for Localized Prostate Cancer

NCT06834152

Conditions
Adenocarcinoma, Carcinoma, Genital Diseases, +20 more
Locations
  • Klinik für Radioonkologie und Strahlentherapie, Universitätsklinikum Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • Klinik und Poliklinik für Strahlentherapie und Radioonkologie, Universitätsklinikum LMU Munich, Bavaria, Germany
  • University Hospital Zurich, Department of Radio-Oncology Zurich, Canton of Zurich, Switzerland
View Trial Details
Recruiting

A Study of TRK-950 When Used in Combination With Ramucirumab and Paclitaxel in Patients With Gastric Cancer

NCT06038578

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +12 more
Locations
  • City of Hope Duarte, California, United States
  • City of Hope at Orange County Lennar Foundation Cancer Center Irvine, California, United States
  • University of California, Los Angeles Santa Monica, California, United States
  • Texas Oncology Arlington North Arlington, Texas, United States
View all 27 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types

NCT04300556

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +33 more
Locations
  • ACRC/Arizona Clinical Research Center, Inc Tucson, Arizona, United States
  • Universty of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Stanford Women's Cancer Center Palo Alto, California, United States
  • University of Miami Coral Gables, Florida, United States
View all 58 locations
View Trial Details

Related conditions